 Hypoglycemic Agents
"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Antihyperglycemics
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Hypoglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 2 | 3 | | 1998 | 0 | 2 | 2 | | 1999 | 3 | 2 | 5 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 2 | 3 | | 2002 | 1 | 2 | 3 | | 2003 | 6 | 1 | 7 | | 2004 | 5 | 6 | 11 | | 2005 | 3 | 11 | 14 | | 2006 | 3 | 6 | 9 | | 2007 | 10 | 10 | 20 | | 2008 | 11 | 8 | 19 | | 2009 | 15 | 17 | 32 | | 2010 | 17 | 7 | 24 | | 2011 | 14 | 9 | 23 | | 2012 | 24 | 5 | 29 | | 2013 | 17 | 14 | 31 | | 2014 | 28 | 14 | 42 | | 2015 | 24 | 10 | 34 | | 2016 | 24 | 13 | 37 | | 2017 | 31 | 20 | 51 | | 2018 | 36 | 19 | 55 | | 2019 | 29 | 14 | 43 | | 2020 | 23 | 40 | 63 | | 2021 | 10 | 37 | 47 | | 2022 | 7 | 50 | 57 | | 2023 | 6 | 36 | 42 | | 2024 | 43 | 36 | 79 | | 2025 | 64 | 14 | 78 | | 2026 | 19 | 4 | 23 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Heerspink HJL, van Raalte DH, Bjornstad P, Bunck MC, Wu P, Tunali I, Milicevic Z, Koeneman L. Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease. Nephrol Dial Transplant. 2026 May 29; 41(6):1058-1068.
-
Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
-
Al Rawashdh N, Patel BV, Wang SM, Zur RM, Anaya P, Kahn EB, Pinsker JE, Sasson-Katchalski R, Trahan AC, Messer LH, Assadi K, Kudva YC, Beck RW. Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Diabetes Obes Metab. 2026 Jul; 28(7):6280-6290.
-
Connery L, Rosenstock J, Rasouli N, Cheng AYY, Liebl A, Wang Q, Pires V, Knights A, Davidson MB, Child CJ. Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes. Diabetes Obes Metab. 2026 Jul; 28(7):6217-6224.
-
Bluestone JA, Herold KC, Sussel L. Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of Insulin. Cold Spring Harb Perspect Med. 2026 05 01; 16(5).
-
Karakus KE, Akturk HK, Kruger D, Ahmann A, Bharvaga A, Langel CR, Ackeifi CA, Rosen J, Pyle L, Snell-Bergeon JK, Shah VN. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care. 2026 May 01; 49(5):718-723.
-
Busti M, Canonico ME, Keramida K, Palazzuoli A, Kato E, Sakata Y, Alexy T, Grupper A, Nodari S, Ojji DB, Sverdlov AL, Guimaraes PO, Musella F, Ambrosy AP, Girerd N, Monzo L. Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie. Heart Fail Rev. 2026 Apr 15; 31(1).
-
Seget S, Rusak E, Pelicand J, Fry M, Sheanon N, Schierloh U, Xatzipsalti M, Malinici E, Tinti D, Neylon O, Bazdarska Y, Cobry E, Hauser E. Automated insulin delivery use in children and adolescents with type 1 diabetes across the world. Diabetes Res Clin Pract. 2026 Jun; 236:113253.
-
Samson SL, Vellanki P, Blonde L, Hirsch IB, Hoang TD, Isaacs SD, Izuora KE, Low Wang CC, Ooi CP, Padilla BI, Schulman-Rosenbaum R, Twining CL, Umpierrez GE, Valencia WM. American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update. Endocr Pract. 2026 Apr; 32(4):473-518.
-
Akturk HK, Karakus KE, Chen B, Walker TC. Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar; 28(3):264-270.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|